Collaboration with Genzymeataluren PTC Therapeutics has an exclusive collaboration with Genzyme Corporation for the development and commercialization of. PTC Therapeutics will commercialize ataluren in the United States and Canada, while Genzyme will commercialize the product in other regions of the world.
PTC announced in February 2009 that it has completed enrollment of a registration directed clinical trial in patients with nonsense mutation Duchenne and Becker muscular dystrophy. The study is a multicenter, the Cystic Fibrosis Foundation Therapeutics Inc. and the National Center for Research Resources supported.Analysis of of 1.6 million mammograms in seven countries has most definitive disclosure so far, whether a popular mammograms search engine take effect to help found cancer provided. In real world the practice, CAD the odds unnecessary returned increases for more tests called for the false-positive results with no clear benefits to the female, said Joshua Fenton, assistant professor at UC Davis Department of Family and Community Medicine. breast were in the a similar stage and size matter that detected or does not radiologist used CAD. .